News

With around 400,000 students, five of the UK’s top 10 research institutions, and more than 20 Nobel prize winners, London has as much claim to be the centre of the country’s science as Oxford or Cambridge. So why does it have such a hard job holding on to its spin-out companies, particularly in life sciences?

US/European move to put more weight behind moves to improve drug development processes and increase’s R&D productivity in the pharmaceutical industry

Following the deadly outbreak of E. coli infections in Germany, scientists in Saarbruecken are providing free access to the pathogen’s genetic regulation data, to spur research into new antibiotics

The Helmholtz is to lead a major investigation into the sustainable development of rice ecosystems in Southeast Asia involving 22 research institutions

The UK climate minister Greg Barker has announced cuts to the feed-in tariff for all solar installations above 50kw, a move of huge significance to the industry

The new National Institute for Bioprocessing Research and Training (NIBRT) has been officially opened to support the development of Ireland’s biopharmaceutical sector

Phase 2 of a joint project by the UK and Indian governments has opened with £5 million available to support collaborations

Six new collaborative projects have been funded by the UK Technology Strategy Board to advance personalised medicine in cancer and lay foundations for national adoption